Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 3
2007 2
2009 1
2010 3
2011 5
2012 3
2013 4
2014 9
2015 7
2016 12
2017 8
2018 5
2019 11
2020 16
2021 16
2022 11
2023 7
2024 12
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Stage III: definitive chemoradiotherapy.
Fietkau R, Semrau S. Fietkau R, et al. Front Radiat Ther Oncol. 2010;42:122-134. doi: 10.1159/000262467. Epub 2009 Nov 24. Front Radiat Ther Oncol. 2010. PMID: 19955798 Review.
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.
Mittelstädt A, Anthuber A, David P, Podolska M, Bénard A, Brunner M, Krautz C, Jacobsen A, Denz A, Weber K, Merkel S, Hackner D, Buniatov T, Roßdeutsch L, Klösch B, Swierzy I, Hansen FJ, Strobel D, Zopf Y, Baur JO, Van Deun J, Immanuel Geppert C, Gießl A, Lettmaier S, Semrau S, Grützmann R, Kouhestani D, Weber GF. Mittelstädt A, et al. Front Immunol. 2024 May 23;15:1253072. doi: 10.3389/fimmu.2024.1253072. eCollection 2024. Front Immunol. 2024. PMID: 38846943 Free PMC article.
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial).
Haderlein M, von der Grün J, Balermpas P, Rödel C, Hautmann MG, Steger F, Bohr C, Hehr T, Stromberger C, Budach V, Schymalla M, Engenhart-Cabillic R, Kocik L, Geinitz H, Nestle U, Klautke G, Scherl C, Gall C, Frey B, Schubert P, Semrau S, Ott O, Kesting M, Iro H, Mueller SK, Fietkau R. Haderlein M, et al. Front Oncol. 2024 Aug 19;14:1447123. doi: 10.3389/fonc.2024.1447123. eCollection 2024. Front Oncol. 2024. PMID: 39224800 Free PMC article.
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfalls.
Putz F, Mengling V, Perrin R, Masitho S, Weissmann T, Rösch J, Bäuerle T, Janka R, Cavallaro A, Uder M, Amarteifio P, Doussin S, Schmidt MA, Dörfler A, Semrau S, Lettmaier S, Fietkau R, Bert C. Putz F, et al. Strahlenther Onkol. 2020 May;196(5):444-456. doi: 10.1007/s00066-020-01604-0. Epub 2020 Mar 23. Strahlenther Onkol. 2020. PMID: 32206842 Free PMC article. Review.
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy.
Maksoud Z, Schmidt MA, Huang Y, Rutzner S, Mansoorian S, Weissmann T, Bert C, Distel L, Semrau S, Lettmaier S, Eyüpoglu I, Fietkau R, Putz F. Maksoud Z, et al. Cancers (Basel). 2022 Mar 17;14(6):1547. doi: 10.3390/cancers14061547. Cancers (Basel). 2022. PMID: 35326697 Free PMC article.
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].
Müller S, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, Schubart C, Mantsopoulos K, Schmidt D, Wiesmueller M, Sievert M, Beck M, Eckstein M, Fietkau R, Iro H, Hecht M. Müller S, et al. Laryngorhinootologie. 2022 Apr;101(4):327-330. doi: 10.1055/a-1540-7017. Epub 2021 Jul 23. Laryngorhinootologie. 2022. PMID: 34298563 German. No abstract available.
115 results